Discordant Outcomes following Failure of Antiretroviral Therapy Are Associated with Substantial Differences in Human Immunodeficiency Virus-Specific Cellular Immunity

Documenti analoghi

• Human Immunodeficiency Virus-Specific CD8(+) T-Cell Responses Do Not Predict Viral Growth and Clearance Rates during Structured Intermittent Antiretroviral Therapy
  di: Oxenius, Annette, et al.
  Pubblicazione: (2002)
• Emergence of Polyfunctional CD8(+) T Cells after Prolonged Suppression of Human Immunodeficiency Virus Replication by Antiretroviral Therapy
  di: Rehr, Manuela, et al.
  Pubblicazione: (2008)
• Low Human Immunodeficiency Virus Envelope Diversity Correlates with Low In Vitro Replication Capacity and Predicts Spontaneous Control of Plasma Viremia after Treatment Interruptions
  di: Joos, Beda, et al.
  Pubblicazione: (2005)
• Reconstitution of Human Thymic Implants Is Limited by Human Immunodeficiency Virus Breakthrough during Antiretroviral Therapy
  di: Amado, Rafael G., et al.
  Pubblicazione: (1999)
• Severe CD4(+) T-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration following Highly Active Antiretroviral Therapy
  di: Guadalupe, Moraima, et al.
  Pubblicazione: (2003)